Improve Medical Instruments Co., Ltd. (300030.SZ)
CNY 6.6
(-2.37%)
CNY 6.6
(-2.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 400.42 Million CNY | -6.07% |
| 2022 | 426.29 Million CNY | -18.78% |
| 2021 | 524.83 Million CNY | 18.61% |
| 2020 | 442.5 Million CNY | -6.03% |
| 2019 | 470.9 Million CNY | -5.78% |
| 2018 | 499.8 Million CNY | -16.67% |
| 2017 | 599.81 Million CNY | 73.09% |
| 2016 | 346.54 Million CNY | 11.74% |
| 2015 | 310.13 Million CNY | 138.26% |
| 2014 | 130.16 Million CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 39.5 Million CNY | 31.67% |
| 2008 | 30 Million CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 408.29 Million CNY | 1.97% |
| 2024 Q2 | 342.7 Million CNY | -16.07% |
| 2024 Q3 | 346.49 Million CNY | 1.86% |
| 2023 Q3 | 415.67 Million CNY | -0.03% |
| 2023 Q4 | 400.42 Million CNY | -3.67% |
| 2023 Q2 | 415.82 Million CNY | -9.28% |
| 2023 Q1 | 458.35 Million CNY | 7.52% |
| 2023 FY | 400.42 Million CNY | -6.07% |
| 2022 Q1 | 538.23 Million CNY | 2.55% |
| 2022 Q3 | 445.47 Million CNY | 7.72% |
| 2022 Q4 | 426.29 Million CNY | -4.31% |
| 2022 FY | 426.29 Million CNY | -18.78% |
| 2022 Q2 | 413.53 Million CNY | -23.17% |
| 2021 Q2 | 435.04 Million CNY | -16.47% |
| 2021 Q3 | 448.28 Million CNY | 3.04% |
| 2021 FY | 524.83 Million CNY | 18.61% |
| 2021 Q1 | 520.84 Million CNY | 17.7% |
| 2021 Q4 | 524.83 Million CNY | 17.07% |
| 2020 Q2 | 440.58 Million CNY | -5.4% |
| 2020 Q4 | 442.5 Million CNY | -0.11% |
| 2020 Q3 | 442.99 Million CNY | 0.55% |
| 2020 FY | 442.5 Million CNY | -6.03% |
| 2020 Q1 | 465.72 Million CNY | -1.1% |
| 2019 Q4 | 470.9 Million CNY | -3.54% |
| 2019 FY | 470.9 Million CNY | -5.78% |
| 2019 Q1 | 446.31 Million CNY | -10.7% |
| 2019 Q2 | 509.88 Million CNY | 14.24% |
| 2019 Q3 | 488.17 Million CNY | -4.26% |
| 2018 FY | 499.8 Million CNY | -16.67% |
| 2018 Q4 | 499.8 Million CNY | -7.32% |
| 2018 Q3 | 539.29 Million CNY | -0.48% |
| 2018 Q2 | 541.89 Million CNY | 2.15% |
| 2018 Q1 | 530.49 Million CNY | -11.56% |
| 2017 Q1 | 477 Million CNY | 37.65% |
| 2017 FY | 599.81 Million CNY | 73.09% |
| 2017 Q4 | 599.81 Million CNY | -6.65% |
| 2017 Q3 | 642.58 Million CNY | -2.75% |
| 2017 Q2 | 660.73 Million CNY | 38.52% |
| 2016 Q3 | 346.84 Million CNY | 10.65% |
| 2016 Q2 | 313.45 Million CNY | 18.38% |
| 2016 Q1 | 264.79 Million CNY | -14.62% |
| 2016 FY | 346.54 Million CNY | 11.74% |
| 2016 Q4 | 346.54 Million CNY | -0.09% |
| 2015 Q4 | 310.13 Million CNY | 23.61% |
| 2015 Q1 | 197.71 Million CNY | 51.9% |
| 2015 FY | 310.13 Million CNY | 138.26% |
| 2015 Q3 | 250.9 Million CNY | 12.26% |
| 2015 Q2 | 223.5 Million CNY | 13.04% |
| 2014 FY | 130.16 Million CNY | 0.0% |
| 2014 Q4 | 130.16 Million CNY | 80.74% |
| 2014 Q3 | 72.01 Million CNY | 260.09% |
| 2014 Q2 | 20 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 Q2 | 4.17 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q3 | - CNY | -100.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q1 | - CNY | -100.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2009 Q2 | 42 Million CNY | 0.0% |
| 2009 Q3 | 40.75 Million CNY | -2.98% |
| 2009 Q4 | 39.5 Million CNY | -3.07% |
| 2009 FY | 39.5 Million CNY | 31.67% |
| 2008 Q4 | 30 Million CNY | 0.0% |
| 2008 FY | 30 Million CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |